title: Anti-tumour necrosis factor therapy in ankylosing spondylitis. A need for guidelines.
authors.forename: D G
authors.initials: DG
authors.lastname: Kassimos
authors.forename: A
authors.initials: A
authors.lastname: Garyfallos
authors.forename: J
authors.initials: J
authors.lastname: Delamere
authors.forename: A
authors.initials: A
authors.lastname: Whallett
authors.forename: G D
authors.initials: GD
authors.lastname: Kitas
mesh_terms: D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D018501:Antirheumatic Agents / Q000627:therapeutic use*; D006801:Humans; D017410:Practice Guidelines as Topic; D013167:Spondylitis, Ankylosing / Q000188:drug therapy*; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors*
chemical_list: D000911:Antibodies, Monoclonal; D018501:Antirheumatic Agents; D014409:Tumor Necrosis Factor-alpha